CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 82 filers reported holding CULLINAN ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,898,410 | -15.9% | 3,414,189 | 0.0% | 12.25% | +9.9% |
| Q2 2023 | $36,736,673 | +7.2% | 3,414,189 | +1.9% | 11.15% | +22.5% |
| Q1 2023 | $34,264,977 | -2.1% | 3,349,460 | +1.0% | 9.10% | -2.4% |
| Q4 2022 | $35,000,089 | -15.8% | 3,317,544 | +2.3% | 9.32% | -16.6% |
| Q3 2022 | $41,578,000 | +6.4% | 3,243,185 | +6.4% | 11.18% | -25.1% |
| Q2 2022 | $39,070,000 | +35.5% | 3,047,609 | +10.7% | 14.92% | +21.7% |
| Q1 2022 | $28,824,000 | -24.6% | 2,753,047 | +11.2% | 12.26% | -3.4% |
| Q4 2021 | $38,215,000 | -24.6% | 2,476,720 | +10.3% | 12.68% | -14.2% |
| Q3 2021 | $50,666,000 | -12.3% | 2,244,841 | +0.1% | 14.79% | +10.1% |
| Q2 2021 | $57,753,000 | -37.1% | 2,242,841 | +1.8% | 13.44% | -26.9% |
| Q1 2021 | $91,774,000 | – | 2,202,407 | – | 18.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |